Stay updated on Apatinib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, signaling a small patch to the study record. No substantive content or study details appear to be altered.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a minor platform update and not altering the study details.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a maintenance update. The study details on the page appear unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page's revision/version label was updated from v3.6.2 to v3.6.3, reflecting a minor update to the page's metadata.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.2, reflecting a platform-level update rather than changes to the study details displayed on the page.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page now notes that recruitment is closed, and adds user guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'; a formatting change to the Intervention/Treatment header and a revision tag update are also included.SummaryDifference0.6%

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.